|
Post by seanismorris on May 25, 2014 16:54:39 GMT -5
Anyone want to speculate if/how Afrezza could help? My opinion is this is why we need Afrezza approved for Type 1 (and it will be). Doctors like to delay (drug) treatment for Type 2 diabetes (recommending diet changes, etc. first) it doesn't sound like that's a good idea with children. ------ FRIDAY, May 23, 2014 (HealthDay News) -- A serious complication of type 1 diabetes called diabetic ketoacidosis (DKA) can cause temporary changes to the brain matter of children newly diagnosed with the disease, researchers say. What's more, those changes may cause a decrease in memory and attention that persists for at least half a year following the diagnosis of type 1 diabetes, the new study reports. "Children and adolescents diagnosed with type 1 diabetes with diabetic ketoacidosis have evidence of brain gray matter shrinkage and white matter swelling," said the study's lead author, Dr. Fergus Cameron, head of diabetes services at Royal Children's Hospital in Victoria, Australia. "While these changes resolve within the first week, there are associated residual cognitive changes -- memory and attention -- that are present six months after diagnosis." Full Article www.webmd.com/diabetes/news/20140523/brain-changes-may-accompany-type-1-diabetes-diagnosis-in-kids
|
|
|
Post by ashiwi on May 26, 2014 5:55:14 GMT -5
One more reason for the need for Afrezza and the reason for Phase 4 studies for Afrezza use in young children.
|
|